Use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers

被引：0
|
作者：
Duffy, Michael J.
Esteva, Francisco J.
Harbeck, Nadia
Hayes, Daniel F.
Molina, Rafael
机构：
来源：
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2013年 / 47卷 / 04期
关键词：
PLASMINOGEN-ACTIVATOR UPA; MINIMUM CLINICAL RECOMMENDATIONS; INTERNATIONAL EXPERT CONSENSUS; LIGAND-BINDING ASSAY; ESTROGEN-RECEPTOR; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; FOLLOW-UP; ADJUVANT CHEMOTHERAPY; PREDICTING RESPONSE;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：731 / 747
页数：17
相关论文
共 50 条
  • [31] Targeting breast, ovarian, and prostate cancers by cytotoxic LHRH analogs.
    Nagy, A
    Schally, AV
    BIOLOGY OF REPRODUCTION, 2004, : 84 - 85
  • [32] Genetic markers may predict risk for lung, prostate, colorectal, and cervical cancers
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (06): : 929 - 930
  • [33] Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid
    Mullins, CD
    Cooke, JL
    Wang, JL
    Shaya, FT
    Van Doren, H
    Brooks, S
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (06) : 809 - 816
  • [34] Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence
    Jacobs, Elizabeth T.
    Kohler, Lindsay N.
    Kunihiro, Andrew G.
    Jurutka, Peter W.
    JOURNAL OF CANCER, 2016, 7 (03): : 232 - 240
  • [35] Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast,testicular, and ovarian cancers
    Bharaj, BB
    Luo, LY
    Jung, K
    Stephan, C
    Diamandis, EP
    PROSTATE, 2002, 51 (01): : 35 - 41
  • [36] USE OF LINKED MARKERS IN BREAST/OVARIAN CANCER FAMILIES
    SCHOFIELD, A
    MILNER, B
    ALLAN, L
    HAITES, N
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (02) : 145 - 145
  • [37] A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Roni T. Falk
    Annetine Cathrine Staff
    Gary Bradwin
    S. Ananth Karumanchi
    Rebecca Troisi
    Cancer Causes & Control, 2016, 27 : 1009 - 1017
  • [38] A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Falk, Roni T.
    Staff, Annetine Cathrine
    Bradwin, Gary
    Karumanchi, S. Ananth
    Troisi, Rebecca
    CANCER CAUSES & CONTROL, 2016, 27 (08) : 1009 - 1017
  • [39] Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Schoen, Robert E.
    Pinsky, Paul F.
    Weissfeld, Joel L.
    Yokochi, Lance A.
    Church, Timothy
    Laiyemo, Adeyinka O.
    Bresalier, Robert
    Hickey, Tom
    Riley, Thomas
    Prorok, Philip C.
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (03) : 612 - 620
  • [40] USE OF BIOLOGICAL MARKERS IN THE DIAGNOSIS OF CANCERS OF UNKNOWN PRIMARY TUMOR
    RUDDON, RW
    NORTON, SE
    SEMINARS IN ONCOLOGY, 1993, 20 (03) : 251 - 260
12345